Publications (1,301) Publications in which a researcher has participated

2023

  1. Cardiorenal benefits of finerenone: protecting kidney and heart

    Annals of Medicine, Vol. 55, Núm. 1, pp. 502-513

  2. Results of a focused cardiac ultrasound program conducted by neurologists within a stroke care network with cardiac imaging units

    Revista Espanola de Cardiologia, Vol. 76, Núm. 2, pp. 103-111

  3. Remnant cholesterol in patients admitted for acute coronary syndromes

    European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 340-348

  4. Prevalence of Hyperuricemia and Its Association with Cardiovascular Risk Factors and Subclinical Target Organ Damage

    Journal of Clinical Medicine, Vol. 12, Núm. 1

  5. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

  6. Implications of Inflammatory and Oxidative Stress Markers in the Attenuation of Nocturnal Blood Pressure Dipping

    Journal of Clinical Medicine, Vol. 12, Núm. 4

  7. European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction

    Advances in Therapy, Vol. 40, Núm. 1, pp. 233-251

  8. Endocardial ganglionated plexi ablation in a patient with cardioinhibitory carotid sinus syndrome

    Revista Espanola de Cardiologia, Vol. 76, Núm. 1, pp. 66-67

  9. Electronic consultation between primary care physicians and cardiologists. An opportunity for patients and healthcare systems

    REC: CardioClinics

  10. Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial

    Pharmaceutics, Vol. 15, Núm. 2

  11. Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses

    European heart journal. Quality of care & clinical outcomes, Vol. 9, Núm. 2, pp. 194-202

  12. Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome

    Thrombosis Research, Vol. 224, pp. 46-51

  13. Detection of the Copy Number Variants of Genes in Patients with Familial Cardiac Diseases by Massively Parallel Sequencing

    Molecular Diagnosis and Therapy, Vol. 27, Núm. 1, pp. 105-113

  14. Demografía, condiciones de vida y bienestar. El papel de la cronicidad

    Atlantic Review of Economics: Revista Atlántica de Economía, Vol. 6, Núm. 1, pp. 7

  15. Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation

    Cells, Vol. 12, Núm. 4

  16. Characterization of Atrial Substrate to Predict the Success of Pulmonary Vein Isolation: The Prospective, Multicenter MASH-AF II (Multipolar Atrial Substrate High Density Mapping in Atrial Fibrillation) Study

    Journal of the American Heart Association, Vol. 12, Núm. 1, pp. e027795

  17. Characterization and Clinical Association of Autoantibodies Against Perilipin 1 in Patients With Acquired Generalized Lipodystrophy

    Diabetes, Vol. 72, Núm. 1, pp. 71-84

  18. Atrial fibrillation as a new prognosis factor in chronic patients after hospitalization: the CHRONIBERIA index

    Scientific Reports, Vol. 13, Núm. 1

  19. Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients

    Transplantation, Vol. 107, Núm. 2, pp. 466-474

  20. A Mass Spectrometry-Based Method of Quantifying the Contribution of the Lysine Polymorphism at Position 171 in Sheep PrP

    Journal of the American Society for Mass Spectrometry, Vol. 34, Núm. 2, pp. 245-254